The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116200009 11620000 9 F 2008 20160922 20151012 20160930 EXP PHHY2015BR121881 NOVARTIS 63.94 YR F Y 76.00000 KG 20160930 OT BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116200009 11620000 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 15 MG, QMO (EVERY 30 DAYS) Y 21008 15 MG VIAL /month
116200009 11620000 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, QMO Y 21008 20 MG VIAL /month
116200009 11620000 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO Y SC432 21008 30 MG VIAL /month
116200009 11620000 4 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, QMO Y 21008 20 MG VIAL /month
116200009 11620000 5 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, EVERY 45 DAYS Y 21008 20 MG VIAL
116200009 11620000 6 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 15 MG, EVERY 45 DAYS Y 21008 15 MG VIAL
116200009 11620000 7 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, EVERY 45 DAYS Y 21008 20 MG VIAL
116200009 11620000 8 C ENALAPRIL ENALAPRIL 1 Oral 1 DF, QD 0 1 DF TABLET QD
116200009 11620000 9 C SELOZOK METOPROLOL SUCCINATE 1 Oral 1 DF, QD 0 1 DF TABLET QD
116200009 11620000 10 C DEPURA CHOLECALCIFEROL 1 Oral 10 DF, QD 0 10 DF DROPS QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116200009 11620000 1 Acromegaly
116200009 11620000 8 Hypertension
116200009 11620000 9 Hypertension
116200009 11620000 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
116200009 11620000 HO
116200009 11620000 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
116200009 11620000 Abasia
116200009 11620000 Arthralgia
116200009 11620000 Bone pain
116200009 11620000 Cholelithiasis
116200009 11620000 Clavicle fracture
116200009 11620000 Concomitant disease aggravated
116200009 11620000 Dengue fever
116200009 11620000 Dysstasia
116200009 11620000 Haemorrhage
116200009 11620000 Hypokinesia
116200009 11620000 Immunodeficiency
116200009 11620000 Inappropriate schedule of drug administration
116200009 11620000 Inflammation
116200009 11620000 Localised infection
116200009 11620000 Pain
116200009 11620000 Pain in extremity
116200009 11620000 Peripheral swelling
116200009 11620000 Pyrexia
116200009 11620000 Road traffic accident
116200009 11620000 Syncope
116200009 11620000 Visual impairment
116200009 11620000 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116200009 11620000 2 2009 0
116200009 11620000 3 2009 0
116200009 11620000 5 2009 0